Compare XEL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XEL | GEHC |
|---|---|---|
| Founded | 1909 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Computer Software: Prepackaged Software |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5B | 38.9B |
| IPO Year | N/A | N/A |
| Metric | XEL | GEHC |
|---|---|---|
| Price | $76.33 | $80.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $83.79 | ★ $88.27 |
| AVG Volume (30 Days) | ★ 5.4M | 3.2M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.01% | 0.17% |
| EPS Growth | N/A | ★ 32.35 |
| EPS | 3.27 | ★ 4.83 |
| Revenue | $14,228,000,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $13.06 | $6.42 |
| Revenue Next Year | $7.62 | $4.34 |
| P/E Ratio | $23.18 | ★ $16.62 |
| Revenue Growth | 3.38 | ★ 3.51 |
| 52 Week Low | $65.21 | $57.65 |
| 52 Week High | $83.01 | $94.80 |
| Indicator | XEL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 43.66 |
| Support Level | $74.35 | $79.52 |
| Resistance Level | $77.05 | $83.21 |
| Average True Range (ATR) | 1.30 | 2.22 |
| MACD | 0.28 | -0.70 |
| Stochastic Oscillator | 81.35 | 17.36 |
Xcel Energy manages utilities serving 3.8 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).